Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern

Substance Use and Misuse

Volumn 52, Issue 8, 2017, Pages 1051-1058

  Al Tayyib, Alia ^a   Koester, Stephen ^b   Langegger, Sig ^c   Raville, Lisa ^d  

^a DENVER PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c AKITA INTERNATIONAL UNIVERSITY   (Japan)

^d Harm Reduction Action Center   (United States)

Author keywords

Heroin; methamphetamine; overdose

Indexed keywords

DIAMORPHINE; METHAMPHETAMINE;

ADOLESCENT; ADULT; AMPHETAMINE DEPENDENCE; COMORBIDITY; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COMORBIDITY; FEMALE; HEPATITIS C; HEROIN; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 85015755395     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826084.2016.1271432     Document Type: Article

References (23)

1. Arreola, S., Bluthenthal, R. N., Wenger, L., Chu, D., Thing, J., & Kral, A. H., (2014). Characteristics of people who initiate injection drug use later in life. Drug and Alcohol Dependence, 138, 244–250.
2. Bluthenthal, R. N., Wenger, L., Chu, D., Lorvick, J., Quinn, B., Thing, J. P., & Kral, A. H., (2015). Factors associated with being asked to initiate someone into injection drug use. Drug and Alcohol Dependence, 149, 252–258.
3. Cedarbaum, E. R., & Banta-Green, C. J., (2016). Health behaviors of young adult heroin injectors in the Seattle area. Drug and Alcohol Dependence, 158, 102–109.
4. Denver Office of Drug Strategy. (2015). Proceedings of the Denver Epidemiology Work Group, Spring 2015 report. Retrieved from http://denverdrugstrategy-public.sharepoint.com/SiteAssets/Pages/Program-Data/DEWG%20Report%20Spring%202015.pdf
5. Harris, J. L., Lorvick, J., Wenger, L., Wilkins, T., Iguchi, M. Y., Bourgois, P., & Kral, A. H., (2013). Low-frequency heroin injection among out-of-treatment, street-recruited injection drug users. Journal of Urban Health, 90(2), 299–306.
6. Heckathorn, D. D., (1997). Respondent-driven sampling:A new approach to the study of hidden populations. Social Problems, 44(2), 174–199.
7. Hopper, K., & Barrow, S. M., (2003). Two genealogies of supported housing and their implications for outcome assessment. Psychiatric Services, 54(1), 50–54.
8. Jenkins, L. M., Banta-Green, C. J., Maynard, C., Kingston, S., Hanrahan, M., Merrill, J. O., & Coffin, P. O., (2011). Risk factors for nonfatal overdose at Seattle-area syringe exchanges. Journal of Urban Health, 88(1), 118–128.
9. Jones, C. M., Logan, J., Gladden, R. M., & Bohm, M. K., (2015). Vital signs:Demographic and substance use trends among heroin users - United States, 2002–2013. MMWR Morbidity and Mortality Weekly Report, 64(26), 719–725.
10. Koester, S., & Langegger, S., (2015, November). “Never be stationary”:Survival drug use in the neoliberal city. Presented at the American Anthropological Association Annual Meeting, Denver, CO.
11. Koester, S., Langegger, S., & Al-Tayyib, A., (2016). Never be stationary:Survival drug use in the neoliberal city. Manuscript submitted for publication.
12. Langegger, S., & Koester, S., (2016a). Dwelling without a home:Denver's splintered public spaces. In M. DeBacker, L. Megaco, G. Varna, & F. Menichellil (Eds.), Criminology meets geography:Order and conflict in public space (pp. 140–159). New York, NY:Routledge.
13. Langegger, S., & Koester, S., (2016b). Invisible homelessness:Anonymity, exposure and the right to the city. Urban Geography, 37, 1030–1048.
14. Meacham, M. C., Rudolph, A. E., Strathdee, S. A., Rusch, M. L., Brouwer, K. C., Patterson, T. L., & Roesch, S. C., (2015). Polydrug use and HIV risk among people who inject heroin in Tijuana, Mexico:A latent class analysis. Substance Use & Misuse, 50(10), 1351–1359.
15. National Drug Early Warning System. (2016). NDEWS Sentinel Community Site advance report 2016:Selected findings for heroin, fentanyl, and methamphetamine. Retrieved from https://ndews.umd.edu/sites/ndews.umd.edu/files/u1424/2016_ndews_scs_advance_report_final.pdf
16. National Institute on Drug Abuse. (2014). Epidemiologic trends in drug abuse:Proceedings of the Community Epidemiology Work Group. Retrieved from https://www.drugabuse.gov/sites/default/files/cewg_jan2014_execsumm.pdf
17. Ochoa, K. C., Davidson, P. J., Evans, J. L., Hahn, J. A., Page-Shafer, K., & Moss, A. R., (2005). Heroin overdose among young injection drug users in San Francisco. Drug and Alcohol Dependence, 80(3), 297–302.
18. Peavy, K. M., Banta-Green, C. J., Kingston, S., Hanrahan, M., Merrill, J. O., & Coffin, P. O., (2012). “Hooked on” prescription-type opiates prior to using heroin:Results from a survey of syringe exchange clients. Journal of Psychoactive Drugs, 44(3), 259–265.
19. Pollini, R. A., & Strathdee, S. A., (2007). Indicators of methamphetamine use and abuse in San Diego County, California:2001–2005. Journal of Psychoactive Drugs, (Suppl 4), 319–325.
20. Roth, A. M., Armenta, R. A., Wagner, K. D., Roesch, S. C., Bluthenthal, R. N., Cuevas-Mota, J., & Garfein, R. S., (2015). Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California:A latent class analysis. Substance Use & Misuse, 50(2), 205–214.
21. Substance Abuse and Mental Health Services Administration. (2015). Behavioral health trends in the United States:Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927). Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.htm
22. U.S. Department of Drug Enforcement Administration. (2016). National heroin threat assessment summary (DEA-DCT-DIR-031-16). Retrieved from https://www.dea.gov/divisions/hq/2015/hq052215_National_Heroin_Threat_Assessment_Summary.pdf
23. U.S. Department of Drug Enforcement Administration. (2015). 2015 national drug threat assessment summary (DEA-DCT-DIR-008-16). Retrieved from https://www.dea.gov/docs/2015%20NDTA%20Report.pdf